Skip to main content
Equibles
FENC logo

FENC · Fennec Pharmaceuticals Inc. · Metrics

Track FENC — free

Use FENC with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

Claude ChatGPT Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$11.75 -0.70 (-5.62%)
Russell 2000 member Rebalance outlook locked
Market Cap
$436.59M
Shares
35.07M

FENC metrics

66 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$12.45
Market cap
$436.59M

Price action

20 metrics
Price change (1W)
+1.0%
Price change (30D)
+13.3%
Price change (3M)
+42.4%
Price change (6M)
+60.9%
Price change (YTD)
+60.9%
Price change (1Y)
+35.0%
Trailing year
Price change (5Y)
+56.0%
52-week high
$12.78
52-week low
$5.77
Change from 52-week high
-3.1%
Change from 52-week low
+114.7%
Annualized volatility
66.4%
Annualized volatility (3M)
60.5%
Beta
1.4
RSI (14D)
59.5
Price vs SMA 50
+12.5%
Price vs SMA 200
+43.4%
Avg volume (3M)
230,613
Relative volume
0.9
Average dollar volume
$2.50M

Company

3 metrics
Sector
Healthcare
Industry
Biotechnology
Shares outstanding
35.07M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
7.3×
reciprocal yield 13.6%
P / book
10.2
reciprocal yield 9.8%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-0.7%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
4.9×
reciprocal yield 20.4%
EV / revenue historical average (5Y)
4.9×
reciprocal yield 20.4%
EV / EBIT historical average (3Y)
46.5×
reciprocal yield 2.2%
EV / EBIT historical average (5Y)
46.5×
reciprocal yield 2.2%
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-11

Profitability

9 metrics
Gross margin
—
Operating margin
-1.9%
Trailing 12 months
Net margin
-5.5%
Gross profit (TTM)
$19.99M
Operating profit (TTM)
−$1.12M
Net income (TTM)
−$3.25M
Trailing 12 months
Diluted EPS (TTM)
$-0.13
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$-0.24

Growth

11 metrics
Revenue growth YoY
+85.2%
Year over year
Net income growth YoY
—
Revenue (TTM)
$59.22M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+31.7%
Year over year · more shares
Revenue CAGR (3Y)
+207.5%
Revenue CAGR (5Y)
+194.9%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-7.7%
Return on assets
-4.3%
Debt / equity
—
Current ratio
5.8
EBITDA (TTM)
−$2.50M
Free cash flow (TTM)
—
Quick ratio
5.8
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$41.25M
Total assets
$75.75M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$2.04M
Capital expenditures (TTM)
$0
R&D (TTM)
$216,000
SG&A (TTM)
—
Stock compensation (TTM)
$7.50M
R&D / revenue
0.4%
Stock compensation / revenue
12.7%

Ownership (13F)

3 metrics
13F filers
106
13F filer change QoQ
+15
Institutional ownership
46.6%

Short interest

3 metrics
Short interest
1.5%
Latest settlement · 2.2 days to cover
Days to cover
2.2d
Short-squeeze score
45 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$1.35M
Insider-sentiment score
45 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1211583 CUSIP 31447P100 13F (30d) 73 filings 73 filers Visit website Investor relations